MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, AVDL made $77,467K in revenue. $20K in net income. Net profit margin of 0.03%.

Income Overview

Revenue
$77,467K
Net Income
$20K
Net Profit Margin
0.03%
Unit: Thousand (K) dollars
Revenue Breakdown
    • Gross profit

Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Net product revenue
77,467 68,129 52,511 33,780*
Cost of products sold
-4,116 6,366 5,577 3,819*
Gross profit
81,583 61,763 46,934 29,961*
Research and development expenses
27,010 4,255 4,354 3,415*
Selling, general and administrative expenses
52,636 48,624 45,581 49,342*
Total operating expense
79,646 52,879 49,935 52,757*
Operating income (loss)
1,937 8,884 -3,001 -22,796*
Investment and other income, net
532 -34 397 1,546*
Interest expense
2,415 2,355 2,238 2,526*
Income (loss) before income taxes
54 6,495 -4,842 -23,776*
Income tax provision (benefit)
34 -3,170 78 385*
Net income (loss)
20 9,665 -4,920 -24,161
Basic EPS
0 0.1 -0.05 -0.26
Diluted EPS
0 0.1 -0.05 -0.26
Basic Average Shares
97,104,000 96,726,000 96,601,000 92,972,000
Diluted Average Shares
101,276,000 99,087,000 96,601,000 92,972,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Gross profit$81,583K (85.97%↑ Y/Y)Net product revenue$77,467K (54.86%↑ Y/Y)Cost of products sold-$4,116K (-166.87%↓ Y/Y)Cost of products sold-$4,116K (-166.87%↓ Y/Y)Gross profit$81,583K (85.97%↑ Y/Y)Operating income (loss)$1,937K (692.35%↑ Y/Y)Investment and otherincome, net$532K (-12.79%↓ Y/Y)Total operatingexpense$79,646K (80.21%↑ Y/Y)Income (loss) beforeincome taxes$54K (102.13%↑ Y/Y)Interest expense$2,415K (-14.36%↓ Y/Y)Selling, general andadministrative expenses$52,636K (30.31%↑ Y/Y)Research and developmentexpenses$27,010K (610.23%↑ Y/Y)Net income (loss)$20K (100.76%↑ Y/Y)Income tax provision(benefit)$34K (-61.36%↓ Y/Y)

AVADEL PHARMACEUTICALS PLC (AVDL)

AVADEL PHARMACEUTICALS PLC (AVDL)